Eurofarma is a Brazilian multinational pharmaceutical company engaged in biopharmaceuticals. Eurofarma is currently seeking antimicrobial small molecules from natural sources for antibacterial drugs/therapies.
Approaches of Interest:
- The highest priority is given to opportunities focusing on antimicrobial small molecules, including both natural products and their derivatives, but there is less interest in peptide-based approaches.
- Priority will be given to bactericidal compounds; however bacteriostatic and adjuvant compounds are still of interest.